Literature DB >> 22105889

Ovarian tumor-derived ectopic hyperprolactinemia.

Autumn F Elms1, S J Carlan, Amy E Rich, Lizardo Cerezo.   

Abstract

To describe extreme hyperprolactinemia originating from a pituitary adenoma in the wall of an ovarian dermoid. This is a description of an unusual case and a review of ectopic prolactin production. Ectopic production of prolactin is a rare condition that has been reported in isolated organ system pathology including ovaries. An ovarian dermoid is a benign neoplasm that has the potential for active unregulated endocrine function. Hyperprolactinemia can result from functioning lactotrophs found in ovarian dermoids and can lead to clinical sequelae. Definitive treatment of the condition requires surgical removal of the functioning endocrine tissue. Extreme hyperprolactinemia caused by a pituitary tumor located within a dermoid has not been reported before. We present a case of profound hyperprolactinemia originating from a pituitary adenoma found in the wall of an ovarian dermoid and give a broad overview of the condition and literature. Ectopic prolactin production should always be considered in symptomatic patients found to have elevated serum levels and no findings on brain imaging.

Entities:  

Mesh:

Year:  2012        PMID: 22105889     DOI: 10.1007/s11102-011-0366-4

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  13 in total

1.  Evaluation and management of the pelvic mass: a review of 540 cases.

Authors:  M A Killackey; R S Neuwirth
Journal:  Obstet Gynecol       Date:  1988-03       Impact factor: 7.661

2.  Ectopic hypophyseal hormonal cells in benign cystic teratoma of the ovary. Light microscopic histochemical dye staining and immunoperoxidase cytochemistry.

Authors:  D W McKeel; F B Askin
Journal:  Arch Pathol Lab Med       Date:  1978-03       Impact factor: 5.534

3.  Anterior pituitary component in benign cystic ovarian teratomas. Report of three cases.

Authors:  M Akhtar; I Young; H Brody
Journal:  Am J Clin Pathol       Date:  1975-07       Impact factor: 2.493

4.  Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine.

Authors:  George I Papakostas; Karen K Miller; Timothy Petersen; Katherine G Sklarsky; Sarah E Hilliker; Anne Klibanski; Maurizio Fava
Journal:  J Clin Psychiatry       Date:  2006-06       Impact factor: 4.384

5.  Ectopic production of prolactin in uterine cervical carcinoma.

Authors:  C T Hsu; M H Yu; C Y Lee; H L Jong; M Y Yeh
Journal:  Gynecol Oncol       Date:  1992-02       Impact factor: 5.482

6.  Cure of postpartum hyperprolactinaemia galactorrhoea-amenorrhoea by removal of benign ovarian teratoma. Two case reports.

Authors:  M H Wahba
Journal:  Br J Obstet Gynaecol       Date:  1980-07

7.  Corticotroph cell pituitary adenoma within an ovarian teratoma. A new cause of Cushing's syndrome.

Authors:  C A Axiotis; H A Lippes; M J Merino; N C deLanerolle; A F Stewart; B Kinder
Journal:  Am J Surg Pathol       Date:  1987-03       Impact factor: 6.394

8.  Ectopic hyperprolactinemia resulting from an ovarian teratoma.

Authors:  G A Kallenberg; C M Pesce; B Norman; R E Ratner; S G Silvergerg
Journal:  JAMA       Date:  1990-05-09       Impact factor: 56.272

9.  Prolactinoma in wall of ovarian dermoid cyst with hyperprolactinemia.

Authors:  P E Palmer; S Bogojavlensky; A K Bhan; R E Scully
Journal:  Obstet Gynecol       Date:  1990-03       Impact factor: 7.661

Review 10.  Long-term management of prolactinomas.

Authors:  Janet A Schlechte
Journal:  J Clin Endocrinol Metab       Date:  2007-08       Impact factor: 5.958

View more
  2 in total

Review 1.  New insights in prolactin: pathological implications.

Authors:  Valérie Bernard; Jacques Young; Philippe Chanson; Nadine Binart
Journal:  Nat Rev Endocrinol       Date:  2015-03-17       Impact factor: 43.330

2.  Ovarian Dermoid Tumor.

Authors:  Mya St Louis; Rohan Mangal; Thor S Stead; Marcos Sosa; Latha Ganti
Journal:  Cureus       Date:  2022-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.